 MERIAN GLOBAL INVESTORS UK Ltd trimmed its position in shares of Eagle Pharmaceuticals Inc NASDAQ:EGRX by 42.1 during the second quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 48,442 shares of the specialty pharmaceutical companys stock after selling 35,275 shares during the ... 